Ekso Bionics Holdings (EKSO) Net Income towards Common Stockholders (2016 - 2025)
Historic Net Income towards Common Stockholders for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to -$1.4 million.
- Ekso Bionics Holdings' Net Income towards Common Stockholders rose 3146.72% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.4 million, marking a year-over-year decrease of 1126.58%. This contributed to the annual value of -$11.3 million for FY2024, which is 2545.07% up from last year.
- Per Ekso Bionics Holdings' latest filing, its Net Income towards Common Stockholders stood at -$1.4 million for Q3 2025, which was up 3146.72% from -$4.0 million recorded in Q2 2025.
- In the past 5 years, Ekso Bionics Holdings' Net Income towards Common Stockholders registered a high of -$1.4 million during Q3 2025, and its lowest value of -$4.6 million during Q4 2021.
- For the 5-year period, Ekso Bionics Holdings' Net Income towards Common Stockholders averaged around -$3.4 million, with its median value being -$3.4 million (2024).
- As far as peak fluctuations go, Ekso Bionics Holdings' Net Income towards Common Stockholders surged by 4288.42% in 2024, and later crashed by 6721.85% in 2025.
- Quarter analysis of 5 years shows Ekso Bionics Holdings' Net Income towards Common Stockholders stood at -$4.6 million in 2021, then increased by 1.87% to -$4.5 million in 2022, then rose by 28.61% to -$3.2 million in 2023, then dropped by 6.19% to -$3.4 million in 2024, then soared by 58.39% to -$1.4 million in 2025.
- Its last three reported values are -$1.4 million in Q3 2025, -$4.0 million for Q2 2025, and -$3.5 million during Q1 2025.